// STATE LEGISLATION TRACKER

Mississippi HB 648: Nurses; allow nurse practitioners and RNs to administer vitamins through IV therapy in a clinical setting.

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Failed

State: Mississippi
Bill: HB 648
Filed: 2024-01-24
Read the bill: OpenStates →
Last reviewed: 2026-10-02

Plain-English Summary

Mississippi HB648 would have allowed licensed nurse practitioners and registered nurses to administer IV fluids containing vitamins in a clinical setting. It does not address peptides, peptide prescribing, telehealth, controlled substances, prescription monitoring, or 503A/503B peptide compounding, so its direct peptide impact is essentially none.

Key Points

Applies to IV vitamin therapy, not peptide injections or peptide prescriptions
Would have expanded NP and RN administration authority in clinical settings
Says IV vitamins would not need to be prepared by a compound pharmacy
No changes to telehealth prescribing or off-label peptide use
No controlled-substance or prescription-monitoring changes

What to Watch For

Note Similar bills could signal state interest in wellness-clinic services adjacent to peptide clinics.

✓

Opportunity If revived, it may clarify NP and RN roles for IV vitamin services, but not peptide care.

Note The compound-pharmacy language appears limited to vitamins and should not be read as peptide policy.

Where the Bill Stands

The bill was referred to the House Public Health and Human Services Committee on January 24, 2024, and died in committee on March 5, 2024.

· Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-11-04 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws